7,571.25

-3.25

-0.04%

51,962.00

-171.00

-0.33%

28,185.75

+58.25

+0.21%

Russell 2000 Futures

2,815.50

-2.30

-0.08%

4.8940

-0.0350

-0.71%

21.15

+1.73

+8.91%

3,935.00

-34.60

-0.87%

76,868.56

-1,419.23

-1.81%

Crude Oil Dec 26

96.99

+0.53

+0.55%

US Private Equity

10,836.30

-14.33

-0.13%

OTC Markets OTCPK - Delayed Quote USD

Sigyn Therapeutics, Inc. (SIGY)

0.0278 -0.0022 (-7.33%)

At close: October 30 at 4:00:00 PM EDT

Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory Diseases

NewMediaWire 7mo ago

SIGY
-7.33%
The Emergence of Blood Purification Devices to Treat Cardiovascular Disease

NewMediaWire 9mo ago

SIGY
-7.33%
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

GlobeNewswire 5mo ago

OGEN

SIGY
-7.33%
Q2 Virtual Investor Summit Presentations Now Available On Demand

ACCESS Newswire 4mo ago

MYRUF

EXOZ

OTMC.V
Sigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTE

NewMediaWire 6mo ago

SIGY
-7.33%
CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events

NewMediaWire 7mo ago

SIGY
-7.33%
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives

NewMediaWire 7mo ago

SIGY
-7.33%
AEMD

Mobilize your Website

View Site in Mobile | Classic

Share by: